WNT3 and neoplasm: In cancer cells, linc00662 has been shown to upregulate WNT3 through binding miR-15a/16/107, activating the WNT/β-catenin signaling pathway, increasing proliferation and migration abilities of tumor cells in vitro, and promoting tumor growth in vivo [23].